News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself


5/9/2012 6:52:33 AM

Par Pharmaceutical Companies Inc, which is under pressure from an activist investor to consider selling itself, posted higher-than-expected results for the fourth straight quarter as most of its products sold well. Ralph Whitworth's Relational Investors LLC raised its stake in the generic drugmaker and asked the company on Tuesday to focus its strategies on a potential takeover. Par's first-quarter net loss from continuing operations was $28.7 million, or 79 cents per share, compared with $108.8 million, or $3.07 per share, last year.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES